MA26796A1 - Derive d'aminotetraline pour la therapie des maladies cardiovasculaires. - Google Patents

Derive d'aminotetraline pour la therapie des maladies cardiovasculaires.

Info

Publication number
MA26796A1
MA26796A1 MA26435A MA26435A MA26796A1 MA 26796 A1 MA26796 A1 MA 26796A1 MA 26435 A MA26435 A MA 26435A MA 26435 A MA26435 A MA 26435A MA 26796 A1 MA26796 A1 MA 26796A1
Authority
MA
Morocco
Prior art keywords
therapy
cardiovascular diseases
aminotetralin
aminotetralin derivative
left ventricular
Prior art date
Application number
MA26435A
Other languages
English (en)
Inventor
Stefano Bongrani
Roberta Razzetti
Maurizio Civelli
Alberto Umile
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/328,434 external-priority patent/US6103760A/en
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA26796A1 publication Critical patent/MA26796A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA26435A 1999-06-09 2001-12-06 Derive d'aminotetraline pour la therapie des maladies cardiovasculaires. MA26796A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/328,434 US6103760A (en) 1995-03-17 1999-06-09 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (1)

Publication Number Publication Date
MA26796A1 true MA26796A1 (fr) 2004-12-20

Family

ID=23280968

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26435A MA26796A1 (fr) 1999-06-09 2001-12-06 Derive d'aminotetraline pour la therapie des maladies cardiovasculaires.

Country Status (27)

Country Link
US (2) US6576671B1 (fr)
EP (1) EP1183046B1 (fr)
JP (1) JP2003501483A (fr)
KR (1) KR20020005772A (fr)
CN (1) CN1354676A (fr)
AT (1) ATE248607T1 (fr)
AU (1) AU766230B2 (fr)
BR (1) BR0012121A (fr)
CA (1) CA2376715A1 (fr)
CZ (1) CZ20014406A3 (fr)
DE (1) DE60004996T2 (fr)
DK (1) DK1183046T3 (fr)
EA (1) EA003830B1 (fr)
EE (1) EE200100663A (fr)
ES (1) ES2206240T3 (fr)
HK (1) HK1044279B (fr)
HU (1) HUP0201650A2 (fr)
IL (1) IL146962A0 (fr)
MA (1) MA26796A1 (fr)
MX (1) MXPA01012638A (fr)
NO (1) NO20016000L (fr)
NZ (1) NZ515727A (fr)
PL (1) PL352119A1 (fr)
PT (1) PT1183046E (fr)
SK (1) SK18012001A3 (fr)
TR (1) TR200103526T2 (fr)
ZA (1) ZA200110091B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions
EP1500392A1 (fr) * 2003-07-24 2005-01-26 CHIESI FARMACEUTICI S.p.A. Dérivés d'aminotétraline comme médicament pour le traitement et la prévention du dysfonctionnement myocardique ischémique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
IT1275935B1 (it) * 1995-03-17 1997-10-24 Chiesi Farma Spa Derivato di aminotetralina per la terapia di malattie cardiovascolari

Also Published As

Publication number Publication date
DE60004996D1 (de) 2003-10-09
EA003830B1 (ru) 2003-10-30
AU5076500A (en) 2001-01-02
DE60004996T2 (de) 2004-07-22
HK1044279B (zh) 2004-01-16
NZ515727A (en) 2003-06-30
HUP0201650A2 (hu) 2002-12-28
NO20016000L (no) 2002-02-11
ATE248607T1 (de) 2003-09-15
CN1354676A (zh) 2002-06-19
CZ20014406A3 (cs) 2002-04-17
CA2376715A1 (fr) 2000-12-21
DK1183046T3 (da) 2004-01-05
US6576671B1 (en) 2003-06-10
ZA200110091B (en) 2002-12-09
SK18012001A3 (sk) 2002-04-04
EP1183046A1 (fr) 2002-03-06
BR0012121A (pt) 2002-05-14
AU766230B2 (en) 2003-10-09
JP2003501483A (ja) 2003-01-14
MXPA01012638A (es) 2002-07-22
PT1183046E (pt) 2003-12-31
EE200100663A (et) 2003-04-15
KR20020005772A (ko) 2002-01-17
EP1183046B1 (fr) 2003-09-03
IL146962A0 (en) 2002-08-14
PL352119A1 (en) 2003-07-28
ES2206240T3 (es) 2004-05-16
NO20016000D0 (no) 2001-12-07
HK1044279A1 (en) 2002-10-18
US20030207944A1 (en) 2003-11-06
TR200103526T2 (tr) 2002-04-22
EA200101159A1 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
WO2002042462A3 (fr) Agents therapeutiques et methodes d'utilisation de ces agents therapeutiques pour traiter une maladie amyloidogenique
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BE2012C040I2 (fr)
PL342099A1 (en) Therapeutic agents
AU7040201A (en) A new use for deferiprone
MA26796A1 (fr) Derive d'aminotetraline pour la therapie des maladies cardiovasculaires.
BG106209A (en) Therapeutic agents
EP1331004A3 (fr) Dérivé de l'aminotétraline pour le traitement de maladies cardiovasculaires
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
MY133957A (en) "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor"
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.
CA2532330A1 (fr) Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation